Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.
暂无分享,去创建一个
T Pawson | T. Pawson | A. Bernstein | R. Paulson | P. van der Geer | X. Piao | X Piao | R Paulson | P van der Geer | A Bernstein | P. Geer | Xianhua Piao
[1] T. Duffy,et al. The mast cell and mast cell disease. , 1995, Journal of the American Academy of Dermatology.
[2] Ursula Klingmüller,et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.
[3] V. Duronio,et al. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[4] C. Heldin,et al. Dimerization of cell surface receptors in signal transduction , 1995, Cell.
[5] Arnold J. Levine,et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.
[6] S Torihashi,et al. Mutation of the proto‐oncogene c‐kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. , 1994, The Journal of physiology.
[7] J. Ihle,et al. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis , 1993, Molecular and cellular biology.
[8] T. Pawson,et al. The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor , 1991, Molecular and cellular biology.
[9] M. Barbacid,et al. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. , 1992, The Journal of biological chemistry.
[10] A. Reith,et al. W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. , 1990, Genes & development.
[11] John Malysz,et al. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity , 1995, Nature.
[12] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[13] T Pawson,et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav , 1994, Molecular and cellular biology.
[14] M. Welham,et al. Steel factor-induced tyrosine phosphorylation in murine mast cells. Common elements with IL-3-induced signal transduction pathways. , 1992, Journal of immunology.
[15] S. Lev,et al. Interkinase domain of kit contains the binding site for phosphatidylinositol 3' kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Zsebo,et al. The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. , 1991, Journal of immunology.
[17] A. Bernstein,et al. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1 , 1996, Nature Genetics.
[18] C. Walsh,et al. Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells , 1994, Molecular and cellular biology.
[19] A. Goldberg,et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.
[20] Aaron Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway , 1994, Cell.
[21] G. Krystal,et al. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells. , 1993, The Journal of biological chemistry.
[22] J. Zheng,et al. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.
[23] H. Serve,et al. Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. , 1994, The Journal of biological chemistry.
[24] Laura H. Tang,et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm , 1996, Nature Genetics.
[25] A. Reith,et al. The Mouse W/c‐kit Locus , 1990, Annals of the New York Academy of Sciences.
[26] Charis Eng,et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling , 1995, Nature.
[27] D. Beier,et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene , 1993, Cell.
[28] Y. Matsuzawa,et al. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation , 1994 .
[29] D. Metcalfe,et al. Classification and diagnosis of mastocytosis: current status. , 1991, The Journal of investigative dermatology.
[30] T Pawson,et al. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.
[31] T. Pawson,et al. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice , 1993, The Journal of experimental medicine.
[32] J. Ihle,et al. Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand , 1993, Molecular and cellular biology.
[33] Tom Maniatis,et al. The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.
[34] Tony Pawson,et al. Protein modules and signalling networks , 1995, Nature.
[35] L. Shultz. Pleiotropic effects of deleterious alleles at the "motheaten" locus. , 1988, Current topics in microbiology and immunology.
[36] al. et,et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B , 1995, Science.
[37] T. Hunter,et al. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.
[38] S. Lev,et al. A specific combination of substrates is involved in signal transduction by the kit‐encoded receptor. , 1991, The EMBO journal.
[39] T. Maniatis,et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.
[40] H. Kitayama,et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. , 1995, Blood.
[41] E. Russell. Hereditary anemias of the mouse: a review for geneticists. , 1979, Advances in genetics.
[42] T. Hunter,et al. Phosphopeptide mapping and phosphoamino acid analysis by electrophoresis and chromatography on thin‐layer cellulose plates , 1994, Electrophoresis.
[43] G. Mills,et al. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling , 1995, The Journal of experimental medicine.
[44] A. Bernstein,et al. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. , 1996, Blood.
[45] Y. Suzuki,et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] Zhou Songyang,et al. Use of an oriented peptide library to determine the optimal substrates of protein kinases , 1994, Current Biology.
[47] R. Angeletti,et al. Protein tyrosine phosphatase-1C is rapidly phosphorylated in tyrosine in macrophages in response to colony stimulating factor-1. , 1992, The Journal of biological chemistry.
[48] A. Ullrich,et al. Growth factor signaling by receptor tyrosine kinases , 1992, Neuron.
[49] L. Ashman,et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. , 1993, The Journal of clinical investigation.
[50] K. Zsebo,et al. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. , 1991, Experimental hematology.
[51] K. Siminovitch,et al. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene , 1993, Nature Genetics.